Goldstein, David

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 3,848

Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells

Apte, M. V., Park, S., Phillips, P. A., Santucci, N., Goldstein, D., Kumar, R. K., Ramm, G. A., Buchler, M., Friess, H., McCarroll, J. A., et al. (2004) · Pancreas

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 591

Anxiety, depression and quality of life in people with pancreatic cancer and their carers

Janda, M., Neale, R. E., Klein, K., O'Connell, D. L., Gooden, H., Goldstein, D., Merrett, N. D., Wyld, D. K., Rowlands, I. J., & Beesley, V. L. (2017) · Pancreatology

Cancer survivorship and carePancreatic and Hepatic Oncology Research

Cited by 101

The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates

Kiely, B. E., Martin, A. J., Tattersall, M. H. N., Nowak, A. K., Goldstein, D., Wilcken, N. R. C., Wyld, D. K., Abdi, E. A., Glasgow, A., Beale, P. J., et al. (2013) · Journal of Clinical Oncology

Palliative Care and End-of-Life IssuesStatistical Methods in Epidemiology

Cited by 62